WSJ -- Thailand’s new health minister announced that he would urge the Thai government to continue to ignore patents on several cancer drugs, disappointing big pharmaceutical companies that had hoped Bangkok might roll back a policy of overriding patents in the name of public health. The drugs’ makers include Roche Holding AG and Novartis AG of Switzerland and Sanofi-Aventis of France.
